Atrozemb® 10/10mg

Active Ingredients:

Each Film Coated Tablet contains Atorvastatin calcium trihydrate 10.82mg Equivalent to Atorvastatin 10mg + Ezetimibe 10mg.

Leaflet, registration license, and pack

Price: 58 L.E/ Strip (10 tablets)

Atrozemb® 20/10mg

Active Ingredients:

Each Film Coated Tablet contains Atorvastatin calcium trihydrate 21.64mg equivalent to Atorvastatin 20mg + Ezetimibe 10mg.

Leaflet, Registration license, and pack.

Price: 58 L.E/ strip (10 tablets)

Atrozemb® 40/10mg

Active Ingredients:

Each Film Coated Tablet contains Atorvastatin calcium trihydrate 43.28mg Equivalent to Atorvastatin 40mg + Ezetimibe 10mg.

Leaflet, registration license, and pack

Price: 62 L.E/ Strip (10 tablets)

Atrozemb® 80/10mg

Active Ingredients:

Each Film Coated Tablet contains Atorvastatin calcium trihydrate 86.56mg equivalent to Atorvastatin 80mg + Ezetimibe 10mg.

Leaflet, Registration license, and pack.

Price: 45 L.E/ strip (10 tablets)

Indications

Prevention of Cardiovascular Events

Atrozemb® is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (CHO) and a history of acute coronary syndrome

(ACS), either previously treated with a statin or not.

Hypercholesterolaemia

Atrozemb® is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate.

Patients not appropriately controlled with a statin alone patients already treated with a statin and ezetimibe Homozygous Familial Hypercholesterolaemia (HoFH)

Atrozemb® is indicated as adjunctive therapy to diet for use in adults with HoFH. Patients may also receive adjunctive treatments (e.g., low-density lipoprotein [LDL] apheresis).